Your browser doesn't support javascript.
loading
Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
Cunha-Oliveira, Teresa; Ferreira, Luciana L; Coelho, Ana Raquel; Deus, Cláudia M; Oliveira, Paulo J.
Affiliation
  • Cunha-Oliveira T; CNC, Center for Neuroscience and Cell Biology, University of Coimbra, UC-Biotech Building, Biocant Park, Cantanhede, Portugal. Electronic address: teresa.oliveira@uc-biotech.pt.
  • Ferreira LL; CNC, Center for Neuroscience and Cell Biology, University of Coimbra, UC-Biotech Building, Biocant Park, Cantanhede, Portugal.
  • Coelho AR; CNC, Center for Neuroscience and Cell Biology, University of Coimbra, UC-Biotech Building, Biocant Park, Cantanhede, Portugal; Institute for Interdisciplinary Research (I.I.I.), University of Coimbra, 3030-789 Coimbra, Portugal.
  • Deus CM; CNC, Center for Neuroscience and Cell Biology, University of Coimbra, UC-Biotech Building, Biocant Park, Cantanhede, Portugal; Institute for Interdisciplinary Research (I.I.I.), University of Coimbra, 3030-789 Coimbra, Portugal.
  • Oliveira PJ; CNC, Center for Neuroscience and Cell Biology, University of Coimbra, UC-Biotech Building, Biocant Park, Cantanhede, Portugal; Institute for Interdisciplinary Research (I.I.I.), University of Coimbra, 3030-789 Coimbra, Portugal.
Toxicol Appl Pharmacol ; 348: 1-13, 2018 06 01.
Article in En | MEDLINE | ID: mdl-29653124

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_energeticas / Bioenergetica Main subject: Doxorubicin / Tumor Suppressor Protein p53 / Myocytes, Cardiac / Energy Metabolism / Induced Pluripotent Stem Cells / Heart Diseases / Antibiotics, Antineoplastic Language: En Journal: Toxicol Appl Pharmacol Year: 2018 Type: Article

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_energeticas / Bioenergetica Main subject: Doxorubicin / Tumor Suppressor Protein p53 / Myocytes, Cardiac / Energy Metabolism / Induced Pluripotent Stem Cells / Heart Diseases / Antibiotics, Antineoplastic Language: En Journal: Toxicol Appl Pharmacol Year: 2018 Type: Article